Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

G1-S Specific Cyclin D1 (B Cell Lymphoma 1 Protein or BCL 1 Oncogene or PRAD1 Oncogene or CCND1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

G1-S Specific Cyclin D1 (B Cell Lymphoma 1 Protein or BCL 1 Oncogene or PRAD1 Oncogene or CCND1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 35 pages

Galanin Receptor Type 2 (GALR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Galanin Receptor Type 2 (GALR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Galanin Receptor Type 2 (GALR2) Drugs in Development by T...

May 2022 36 pages

Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABA(A) Receptor Subunit Alpha 1 or GABRA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABA(A) Receptor Subunit Alpha 1 or GABRA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUM...

May 2022 38 pages

Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA(A) Receptor or GABR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA(A) Receptor or GABR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Gamma-Aminobut...

May 2022 155 pages

Gamma-Aminobutyric Acid Type B Receptor Subunit (Gamma Aminobutyric Acid (GABA) B Receptor or GABBR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gamma-Aminobutyric Acid Type B Receptor Subunit (Gamma Aminobutyric Acid (GABA) B Receptor or GABBR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 48 pages

Gap Junction Alpha 1 Protein (Connexin 43 or Gap Junction 43 Kda Heart Protein or GJA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gap Junction Alpha 1 Protein (Connexin 43 or Gap Junction 43 Kda Heart Protein or GJA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY G...

May 2022 42 pages

Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastric Motility Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 36 pages

Gastrin-Cholecystokinin Type B Receptor (Cholecystokinin 2 Receptor or CCKBR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gastrin-Cholecystokinin Type B Receptor (Cholecystokinin 2 Receptor or CCKBR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Gastrin/Cho...

May 2022 39 pages

Gastroesophageal (GE) Junction Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gastroesophageal (GE) Junction Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastroesophageal (GE) Junction Carcinomas Drugs in Development by Stag...

May 2022 142 pages

Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastrointestinal Radiation Toxicity Drugs in Development by Stages, Target,...

May 2022 38 pages

Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gastroparesis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 48 pages

Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 46 pages

Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type II Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 35 pages

Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Gaucher Disease Type III Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 41 pages

Gelsolin (AGEL or Actin Depolymerizing Factor or Brevin or GSN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gelsolin (AGEL or Actin Depolymerizing Factor or Brevin or GSN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Gelsolin (AGEL or Actin D...

May 2022 40 pages

General Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

General Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY General Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 43 pages

Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Generalized Anxiety Disorder (GAD) Drugs in Development by Stages, Target, Mo...

May 2022 48 pages

Genital Warts (Condylomata Acuminata) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Genital Warts (Condylomata Acuminata) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Genital Warts (Condylomata Acuminata) Drugs in Development by Stages, Targ...

May 2022 57 pages

Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 77 pages

Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 47 pages

Giant Cell Arteritis (Temporal Arteritis-Cranial Arteritis-Horton Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Giant Cell Arteritis (Temporal Arteritis-Cranial Arteritis-Horton Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Giant Cell Arteritis (Temporal Arteri...

May 2022 36 pages

Globohexaosylceramide (Globo H) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Globohexaosylceramide (Globo H) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Globohexaosylceramide (Globo H) Drugs in Development by T...

May 2022 36 pages

Glucagon Like Peptide 1 Receptor (GLP1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Glucagon Like Peptide 1 Receptor (GLP1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Glucagon Like Peptide 1 Receptor (GLP1R) Drugs i...

May 2022 234 pages

Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Gl...

May 2022 174 pages

Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Gluco...

May 2022 36 pages

Glutamate Ionotropic Receptor AMPA Type Subunit (AMPA Receptor or GRIA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Glutamate Ionotropic Receptor AMPA Type Subunit (AMPA Receptor or GRIA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Glutamate Ionotro...

May 2022 54 pages

Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Glutamate Ionotropic Rece...

May 2022 143 pages

Glutaminase (Glutamine Aminohydrolase or EC 3.5.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Glutaminase (Glutamine Aminohydrolase or EC 3.5.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Glutaminase (Glutamine Aminohydrolas...

May 2022 39 pages

Glyceraldehyde 3 Phosphate Dehydrogenase (Peptidyl Cysteine S Nitrosylase GAPDH or GAPDH or EC 1.2.1.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Glyceraldehyde 3 Phosphate Dehydrogenase (Peptidyl Cysteine S Nitrosylase GAPDH or GAPDH or EC 1.2.1.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 35 pages

Glycogen Storage Disease 1A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Glycogen Storage Disease 1A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Glycogen Storage Disease 1A Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 38 pages

Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Glycogen Storage Disorders (GSD) Drugs in Development by Stages, Target, MoA, R...

May 2022 47 pages

Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Glycogen Synthase Kinase 3 (GSK3 or EC...

May 2022 62 pages

Glycoprotein 140 (gp140) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Glycoprotein 140 (gp140) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Glycoprotein 140 (gp140) Drugs in Development by Therapy Areas a...

May 2022 40 pages

GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) Drugs...

May 2022 45 pages

Gonadotropin Releasing Hormone Receptor (GNRHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gonadotropin Releasing Hormone Receptor (GNRHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Gonadotropin Releasing Hormone Receptor (...

May 2022 65 pages

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY GPI Anchored Wall Transfer Prote...

May 2022 35 pages

Granulocyte Colony Stimulating Factor Receptor (CD114 or GCSFR or CSF3R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Granulocyte Colony Stimulating Factor Receptor (CD114 or GCSFR or CSF3R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Granulocyte Colo...

May 2022 82 pages

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Playe...

May 2022 43 pages

Growth-Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prostate Differentiation Factor or GDF15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Growth-Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prostate Differentiation Factor or GDF15) Drugs in Devel...

May 2022 40 pages

Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 60 pages

Growth Hormone Receptor (Somatotropin Receptor or GHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Growth Hormone Receptor (Somatotropin Receptor or GHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Growth Hormone Receptor (Somatotro...

May 2022 67 pages

GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY GTPase KRas (KRas 2 or Ki...

May 2022 159 pages

Guanine Nucleotide Exchange C9orf72 (C9orf72) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Guanine Nucleotide Exchange C9orf72 (C9orf72) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Guanine Nucleotide Exchange C9orf72 (C9orf7...

May 2022 40 pages

Guanylate Cyclase (Guanylyl Cyclase or GTP Diphosphate-Lyase (Cyclizing) or GC or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Guanylate Cyclase (Guanylyl Cyclase or GTP Diphosphate-Lyase (Cyclizing) or GC or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUM...

May 2022 71 pages

Haemophilus influenzae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Haemophilus influenzae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Haemophilus influenzae Infections Drugs in Development by Stages, Target, MoA,...

May 2022 52 pages

Hantavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hantavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hantavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 40 pages

Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 100 pages

Heat Shock Factor Protein 1 (Heat Shock Transcription Factor 1 or HSF1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Heat Shock Factor Protein 1 (Heat Shock Transcription Factor 1 or HSF1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Heat Shock Factor...

May 2022 40 pages

Heat Shock Protein 70 (HSP70) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Heat Shock Protein 70 (HSP70) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Heat Shock Protein 70 (HSP70) Drugs in Development by Thera...

May 2022 53 pages

Heat Shock Protein 90 (HSP90) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Heat Shock Protein 90 (HSP90) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Heat Shock Protein 90 (HSP90) Drugs in Development by Thera...

May 2022 79 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...